Scott Morrison
Direktor/Vorstandsmitglied bei
IDEAYA BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Scott William Morrison is currently an Independent Director at Zai Lab Ltd. since 2021, IDEAYA Biosciences, Inc. since 2018, Tarsus Pharmaceuticals, Inc. since 2022, and Vera Therapeutics, Inc. since 2020.
Former positions include Independent Director at Global Blood Therapeutics, Inc. from 2015 to 2022, Independent Director at Astellas Gene Therapies, Inc. from 2015 to 2020, Independent Director at ESCAPE Bio, Inc. from 2020 to 2022, Independent Director at Corvus Pharmaceuticals, Inc. from 2015 to 2026, Partner at Ernst & Young LLP from 1996 to 2015, and Director roles at Biotechnology Innovation Organization, Symic Bio, Inc., The Bay Area Bioscience Association, The Biotechnology Institute (also Treasurer), The Life Sciences Foundation, and California Life Sciences Association.
Education includes undergraduate studies at Haas School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 10’700 ( 0.02% ) | 635 580 $ | 31.05.2026 | |
ZAI LAB LTD. 0.03% | 10.04.2026 | 345’330 ( 0.03% ) | 612 899 $ | 31.05.2026 |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 12.06.2025 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 21.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Scott Morrison
| Unternehmen | Position | Beginn |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.07.2018 |
| VERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2020 |
| ZAI LAB LIMITED | Direktor/Vorstandsmitglied | 13.10.2021 |
| TARSUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 06.10.2022 |
Ehemalige bekannte Positionen von Scott Morrison
| Unternehmen | Position | Ende |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 23.04.2026 |
ESCAPE Bio, Inc.
 ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Direktor/Vorstandsmitglied | 01.11.2022 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 04.10.2022 |
| AUDENTES THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.01.2020 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01.12.2015 |
Ausbildung von Scott Morrison
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Symic Bio, Inc.
 Symic Bio, Inc. BiotechnologyHealth Technology Develops new category of therapeutics | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
The Bay Area Bioscience Association
 The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
The Life Sciences Foundation
 The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services Engages in education and biotechnology information dissemination | Commercial Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Tarsus Pharmaceuticals, Inc.
 Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
